Ionis Pharmaceuticals, Inc.
Antisense modulation of PTP1B expression
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of PTP1B mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate metabolic disease, for example, diabetes, or a symptom thereof.
Status:
Grant
Type:
Utility
Filling date:
15 Jun 2016
Issue date:
23 Jun 2020